Ahmad Abdul-Fattah

Title: Ahmad Abdul-Fattah: Innovator in Factor VIII Polypeptide Formulations

Introduction

Ahmad Abdul-Fattah is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII polypeptide formulations. With a total of 3 patents to his name, his work has the potential to greatly impact the treatment of hemophilia.

Latest Patents

One of Ahmad's latest patents focuses on Factor VIII polypeptide formulations. This invention provides a formulation of a Factor VIII polypeptide, such as FVIII-Fc, along with methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be utilized for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Career Highlights

Ahmad Abdul-Fattah is currently employed at Bioverativ Therapeutics Inc., where he continues to innovate in the field of hemophilia treatment. His expertise and dedication to research have positioned him as a key player in the biotechnology industry.

Collaborations

Ahmad has collaborated with several professionals in his field, including Daniel Gage and Kevin Maloney. These collaborations have further enhanced his research and development efforts.

Conclusion

Ahmad Abdul-Fattah is a distinguished inventor whose work in Factor VIII polypeptide formulations is paving the way for advancements in hemophilia treatment. His contributions to biotechnology are invaluable and continue to inspire innovation in the field.